Abstract
No data are available regarding the safety and efficacy of B-cell depletion in the spondyloarthropathies (SpA), except for two case reports. One patient with ankylosing spondylitis (AS) was prescribed rituximab...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
